$GLTO
Galecto, Inc.

2023 Q3 Form 10-Q Financial Statement

#000095017023035925 Filed on July 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.300M $3.070M $3.414M
YoY Change 5.5% -10.08% -6.03%
% of Gross Profit
Research & Development $2.551M $8.089M $13.71M
YoY Change -75.69% -40.99% 58.74%
% of Gross Profit
Depreciation & Amortization $211.0K $17.00K $7.000K
YoY Change 3416.67% 142.86% 250.0%
% of Gross Profit
Operating Expenses $8.583M $11.16M $17.12M
YoY Change -36.99% -34.82% 39.56%
Operating Profit -$8.583M -$11.16M -$17.12M
YoY Change -36.99% -34.82% 39.56%
Interest Expense $450.0K $415.0K $234.0K
YoY Change -516.67% 77.35% -788.24%
% of Operating Profit
Other Income/Expense, Net $447.0K $415.0K $234.0K
YoY Change -513.89% 77.35% -788.24%
Pretax Income -$8.140M -$10.74M -$16.89M
YoY Change -40.71% -36.38% 37.27%
Income Tax
% Of Pretax Income
Net Earnings -$8.136M -$10.74M -$16.89M
YoY Change -40.74% -36.38% 37.27%
Net Earnings / Revenue
Basic Earnings Per Share -$0.30 -$0.41 -$0.67
Diluted Earnings Per Share -$0.30 -$0.41 -$668.3K
COMMON SHARES
Basic Shares Outstanding 27.11M 25.67M 25.26M
Diluted Shares Outstanding 27.10M 26.38M 25.27M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $44.20M $52.12M $79.03M
YoY Change -36.02% -34.04% -22.38%
Cash & Equivalents $23.08M $22.96M $29.80M
Short-Term Investments $21.10M $29.17M $49.23M
Other Short-Term Assets $200.0K $493.0K $962.0K
YoY Change -31.27% -48.75% 5.6%
Inventory
Prepaid Expenses
Receivables $1.400M $1.553M $1.068M
Other Receivables $1.200M $1.192M $1.146M
Total Short-Term Assets $47.10M $55.36M $82.20M
YoY Change -33.85% -32.65% -23.68%
LONG-TERM ASSETS
Property, Plant & Equipment $125.0K $961.0K $205.0K
YoY Change -63.02% 368.78% 16.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00 $6.888M
YoY Change -100.0% -100.0% -80.79%
Other Assets $2.417M $2.480M $3.009M
YoY Change -13.89% -17.58% 167.23%
Total Long-Term Assets $2.949M $3.441M $10.66M
YoY Change -72.76% -67.71% -72.76%
TOTAL ASSETS
Total Short-Term Assets $47.10M $55.36M $82.20M
Total Long-Term Assets $2.949M $3.441M $10.66M
Total Assets $50.05M $58.80M $92.86M
YoY Change -38.98% -36.67% -36.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.477M $5.557M $2.815M
YoY Change 134.77% 97.41% 77.6%
Accrued Expenses $8.078M $2.190M $4.673M
YoY Change 16.21% -53.14% 47.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.60M $14.90M $7.500M
YoY Change 41.57% 98.63% 56.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.0K $206.0K $305.0K
YoY Change -77.27% -32.46% -51.97%
Total Long-Term Liabilities $100.0K $206.0K $305.0K
YoY Change -77.27% -32.46% -51.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.60M $14.90M $7.500M
Total Long-Term Liabilities $100.0K $206.0K $305.0K
Total Liabilities $12.67M $15.10M $7.793M
YoY Change 36.23% 93.8% 44.58%
SHAREHOLDERS EQUITY
Retained Earnings -$249.6M -$241.5M -$189.9M
YoY Change 22.53% 27.17% 46.08%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $37.38M $43.70M $85.07M
YoY Change
Total Liabilities & Shareholders Equity $50.05M $58.80M $92.86M
YoY Change -38.98% -36.67% -36.75%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$8.136M -$10.74M -$16.89M
YoY Change -40.74% -36.38% 37.27%
Depreciation, Depletion And Amortization $211.0K $17.00K $7.000K
YoY Change 3416.67% 142.86% 250.0%
Cash From Operating Activities -$8.460M -$7.849M -$14.84M
YoY Change -14.09% -47.11% 32.86%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $26.00K
YoY Change -100.0% -100.0% -123.64%
Acquisitions
YoY Change
Other Investing Activities $8.280M $3.091M -$77.00K
YoY Change -2.01% -4114.29% -101.47%
Cash From Investing Activities $8.280M $3.091M -$51.00K
YoY Change -0.38% -6160.78% -101.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 170.0K 2.682M 18.00K
YoY Change -59.91% 14800.0%
NET CHANGE
Cash From Operating Activities -8.460M -7.849M -14.84M
Cash From Investing Activities 8.280M 3.091M -51.00K
Cash From Financing Activities 170.0K 2.682M 18.00K
Net Change In Cash -10.00K -2.076M -14.87M
YoY Change -99.1% -86.04% 145.96%
FREE CASH FLOW
Cash From Operating Activities -$8.460M -$7.849M -$14.84M
Capital Expenditures $0.00 $0.00 $26.00K
Free Cash Flow -$8.460M -$7.849M -$14.87M
YoY Change -12.86% -47.2% 34.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001800315
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
CY2023Q2 glto Debt Securities Available For Sales Type Extensible List
DebtSecuritiesAvailableForSalesTypeExtensibleList
us-gaap:CorporateDebtSecuritiesMember
CY2022Q4 glto Debt Securities Available For Sales Type Extensible List
DebtSecuritiesAvailableForSalesTypeExtensibleList
us-gaap:CorporateDebtSecuritiesMember
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39655
dei Entity Registrant Name
EntityRegistrantName
GALECTO, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1957007
dei Entity Address Address Line1
EntityAddressAddressLine1
75 State Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02109
dei City Area Code
CityAreaCode
+45
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Local Phone Number
LocalPhoneNumber
70 70 52 10
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
GLTO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25652392
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27112697
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22956000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32786000
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
29168000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
27438000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3238000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3686000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
55362000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
63910000
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
5832000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
633000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
810000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
328000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
357000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2480000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2279000
CY2023Q2 us-gaap Assets
Assets
58803000
CY2022Q4 us-gaap Assets
Assets
73188000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5557000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3350000
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
9340000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7757000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14897000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11107000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
206000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
328000
CY2023Q2 us-gaap Liabilities
Liabilities
15103000
CY2022Q4 us-gaap Liabilities
Liabilities
11435000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27021899
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27021899
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25652392
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
285311000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
279733000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-241474000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-217736000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-137000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-244000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43700000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
61753000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58803000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73188000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8089000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13707000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18451000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26942000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3070000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3414000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6200000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7118000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
11159000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
17121000
us-gaap Operating Expenses
OperatingExpenses
24651000
us-gaap Operating Expenses
OperatingExpenses
34060000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11159000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17121000
us-gaap Operating Income Loss
OperatingIncomeLoss
-24651000
us-gaap Operating Income Loss
OperatingIncomeLoss
-34060000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
442000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
156000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
876000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
217000
CY2022Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-70000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-70000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-27000
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
148000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
37000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
88000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
415000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
234000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
913000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
235000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10744000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-16887000
us-gaap Net Income Loss
NetIncomeLoss
-23738000
us-gaap Net Income Loss
NetIncomeLoss
-33825000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.34
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26375076
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26375076
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25270314
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25270314
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26025929
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26025929
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25266096
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25266096
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-719000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-889000
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
25000
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-155000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
117000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-360000
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-70000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-70000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-10000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-804000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
107000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1179000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10754000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17691000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23631000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35004000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
50333000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1439000
CY2023Q2 glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
100000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2682000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10744000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43700000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
101314000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1419000
CY2022Q2 glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
100000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-804000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-16887000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
85065000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
61753000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2873000
glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
100000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2705000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
107000
us-gaap Net Income Loss
NetIncomeLoss
-23738000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43700000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
117223000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2823000
glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
100000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1179000
us-gaap Net Income Loss
NetIncomeLoss
-33825000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
85065000
us-gaap Profit Loss
ProfitLoss
-23738000
us-gaap Profit Loss
ProfitLoss
-33825000
us-gaap Depreciation
Depreciation
35000
us-gaap Depreciation
Depreciation
15000
us-gaap Share Based Compensation
ShareBasedCompensation
2873000
us-gaap Share Based Compensation
ShareBasedCompensation
2823000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
248000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-438000
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-70000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
199000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
207000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
30000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
28000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-450000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6740000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
203000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
981000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2207000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1284000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1639000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1790000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-227000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-226000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16983000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21637000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
21994000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
40656000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
26459000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
30415000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4465000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10258000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2705000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2705000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2823000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9813000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-31877000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-17000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-891000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32786000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62563000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22956000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29795000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-241500000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-10700000
us-gaap Profit Loss
ProfitLoss
-23700000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-16900000
us-gaap Profit Loss
ProfitLoss
-33800000
CY2023Q2 us-gaap Investments And Cash
InvestmentsAndCash
52100000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
55400000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14900000
CY2022Q4 us-gaap Investments And Cash
InvestmentsAndCash
66100000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
63900000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11100000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
425000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
419000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
97000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
328000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
357000
CY2023Q2 us-gaap Depreciation
Depreciation
17000
us-gaap Depreciation
Depreciation
35000
CY2022Q2 us-gaap Depreciation
Depreciation
7000
us-gaap Depreciation
Depreciation
15000
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
39646000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
49715000
CY2023Q2 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
1553000
CY2022Q4 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
1450000
CY2023Q2 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
802000
CY2022Q4 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
792000
CY2023Q2 us-gaap Prepaid Insurance
PrepaidInsurance
339000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
805000
CY2023Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
390000
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
587000
CY2023Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
154000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
52000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3238000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3686000
CY2023Q2 glto Operating Lease Rent Expense
OperatingLeaseRentExpense
100000
glto Operating Lease Rent Expense
OperatingLeaseRentExpense
300000
CY2022Q2 glto Operating Lease Rent Expense
OperatingLeaseRentExpense
100000
glto Operating Lease Rent Expense
OperatingLeaseRentExpense
200000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
139000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
117000
us-gaap Operating Lease Cost
OperatingLeaseCost
276000
us-gaap Operating Lease Cost
OperatingLeaseCost
243000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
125000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
120000
us-gaap Operating Lease Payments
OperatingLeasePayments
273000
us-gaap Operating Lease Payments
OperatingLeasePayments
234000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
409000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
270000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
316000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
68000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
664000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
38000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
626000
CY2023Q2 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
6695000
CY2022Q4 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
6145000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1770000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
597000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
420000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
476000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
455000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
539000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9340000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7757000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5778885
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.43
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1923350
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.28
glto Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
433020
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
31525
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.58
glto Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledIntrinsicValue
11445
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7670710
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.40
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3256209
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7366568
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.36
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y2M12D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3256209
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3670775
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
5.39
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y6M
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
744040
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1439000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1419000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2873000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.038
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.910
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.900
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10744000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-16887000
us-gaap Net Income Loss
NetIncomeLoss
-23738000
us-gaap Net Income Loss
NetIncomeLoss
-33825000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26375076
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26375076
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25270314
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25270314
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26025929
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26025929
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25266096
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25266096
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.34

Files In Submission

Name View Source Status
0000950170-23-035925-index-headers.html Edgar Link pending
0000950170-23-035925-index.html Edgar Link pending
0000950170-23-035925.txt Edgar Link pending
0000950170-23-035925-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
glto-20230630.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
glto-20230630.xsd Edgar Link pending
glto-ex31_1.htm Edgar Link pending
glto-ex31_2.htm Edgar Link pending
glto-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
glto-20230630_def.xml Edgar Link unprocessable
glto-20230630_lab.xml Edgar Link unprocessable
glto-20230630_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
glto-20230630_cal.xml Edgar Link unprocessable
glto-20230630_pre.xml Edgar Link unprocessable